Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now?

Intuitive Surgical and Stryker represent two distinct approaches to robotic-assisted surgery. ISRG demonstrates stronger operational momentum with 16% procedure growth and expanding digital ecosystem, earning a Zacks Rank #2 (Buy) rating. Stryker shows recovery potential with record Mako installations and diversified MedTech portfolio but receives a Zacks Rank #3 (Hold) rating. ISRG trades at a premium valuation (34.54X P/E) reflecting growth expectations, while SYK trades at a discount (16.95X P/E) providing valuation support.